Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
genentech
3
×
indiana blog main
3
×
indiana top stories
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
3
×
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
eli lilly
national
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
What
cancer
drug
latest
address
alzheimer’s
annual
approval
approves
bio
blueprint
breast
cancer's
carries
certain
clinical
companies
conference
data
designed
different
esmo
european
fail
fda
gene
genetic
increases
lines
lung
medical
medicines
meds
oncology
pass
pharmaceutical
plan
precision
prescription
price
prices
Language
unset
Current search:
genentech
×
roche
×
" indiana blog main "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front